Literature DB >> 8560266

Receptor-ligand interaction between CD44 and osteopontin (Eta-1).

G F Weber1, S Ashkar, M J Glimcher, H Cantor.   

Abstract

The CD44 family of surface receptors regulates adhesion, movement, and activation of normal and neoplastic cells. The cytokine osteopontin (Eta-1), which regulates similar cellular functions, was found to be a protein ligand of CD44. Osteopontin induces cellular chemotaxis but not homotypic aggregation, whereas the inverse is true for the interaction between CD44 and a carbohydrate ligand, hyaluronate. The different responses of cells after CD44 ligation by either osteopontin or hyaluronate may account for the independent effects of CD44 on cell migration and growth. This mechanism may also be exploited by tumor cells to promote metastasis formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8560266     DOI: 10.1126/science.271.5248.509

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  226 in total

1.  Lactosomes: structural and compositional classification of unique nanometer-sized protein lipid particles of human milk.

Authors:  Nurit Argov-Argaman; Jennifer T Smilowitz; Daniel A Bricarello; Mariana Barboza; Larry Lerno; John W Froehlich; Hyeyoung Lee; Angela M Zivkovic; Danielle G Lemay; Samara Freeman; Carlito B Lebrilla; Atul N Parikh; J Bruce German
Journal:  J Agric Food Chem       Date:  2010-10-06       Impact factor: 5.279

2.  Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells.

Authors:  Z Zheng; R D Cummings; P E Pummill; P W Kincade
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  A Photo-clickable ATP-Mimetic Reveals Nucleotide Interactors in the Membrane Proteome.

Authors:  Mark Jelcic; Ke Wang; King Lam Hui; Xiao-Chuan Cai; Balázs Enyedi; Minkui Luo; Philipp Niethammer
Journal:  Cell Chem Biol       Date:  2020-06-09       Impact factor: 8.116

4.  Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model.

Authors:  Keisuke Ohno; Hidefumi Nishimori; Takahiro Yasoshima; Kenjiro Kamiguchi; Fumitake Hata; Rika Fukui; Koichi Okuya; Yasutoshi Kimura; Ryuichi Denno; Shigeyuki Kon; Toshimitsu Uede; Noriyuki Sato; Koichi Hirata
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

5.  A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach.

Authors:  Albert Ries; Jeffrey L Goldberg; Barbara Grimpe
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

6.  Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.

Authors:  Dennis Bruemmer; Alan R Collins; Grace Noh; Wei Wang; Mary Territo; Sarah Arias-Magallona; Michael C Fishbein; Florian Blaschke; Ulrich Kintscher; Kristof Graf; Ronald E Law; Willa A Hsueh
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Two different functions for CD44 proteins in human myelopoiesis.

Authors:  J Moll; S Khaldoyanidi; J P Sleeman; M Achtnich; I Preuss; H Ponta; P Herrlich
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 8.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

9.  Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barré syndrome.

Authors:  Rong Kun Han; Yue Feng Cheng; Shan Shan Zhou; Hong Guo; Rui Dong He; Li Jun Chi; Li Ming Zhang
Journal:  J Clin Immunol       Date:  2013-11-12       Impact factor: 8.317

10.  Epithelial Ovarian Cancer and Cancer Stem Cells.

Authors:  Amr A Soliman; Alaa A Elzarkaa; Eduard Malik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.